Protocol for the examination of specimens from patients with hematopoietic neoplasms of the bone marrow: A basis for checklists

Archives of Pathology and Laboratory Medicine

Volumn 126, Issue 9, 2002, Pages 1050-1056

  Peterson, LoAnn C ^a   Agosti, Steven J ^b   Hoyer, James D ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW BIOPSY; BONE MARROW CANCER; CHROMOSOME ANALYSIS; CYTOCHEMISTRY; FLOW CYTOMETRY; HEMATOPOIETIC SYSTEM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOID TISSUE; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL SPECIALIST; MOLECULAR BIOLOGY; QUANTITATIVE ANALYSIS; WORLD HEALTH ORGANIZATION;

BONE MARROW NEOPLASMS; CANADA; CLINICAL PROTOCOLS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MEDICAL RECORDS; PATHOLOGY, SURGICAL; SPECIMEN HANDLING; UNITED STATES;

EID: 0036770445     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bain BJ. The bone marrow aspirate of healthy subjects. Br J Haematol 1996; 94:206-209.
2. Jennings CD, Foon KA. Review: recent advances in flow cytometry application to the diagnosis of hematologic malignancy. Blood. 1997;90:2863-2892.
3. LeBeau MM. Role of Cytogenetics in the Diagnosis and Classification of Hematopoietic Neoplasms. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:391-418.
4. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
5. Bagg A, Kallakury BVS. Molecular pathology of leukemia and lymphoma. Am J Clin Pathol. 1999; 112(suppl 1):S76-S92.
6. Bennett JM, Catovsky D, Daniel MT, et al. Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7): a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:460-462.
7. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199.
8. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:620-625.
9. Bennett JM, Catovsky D, Daniel MT, et al. The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Br J Haematol. 1994;87:746-754.
10. Brunning RD, McKenna RW. Tumors of the Bone Marrow. Washington, DC: Armed Forces Institute of Pathology; 1994.
11. Brynes RK, McKenna RW, Sundberg RD. Bone marrow aspiration and trephine biopsy. Am J Clin Pathol. 1978;70:753-759.
12. Cheson BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institutesponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8:813-819.
13. Fenaux P, Morel P, Lai JL. Cytogenetics of myelodysplastic syndromes. Semin Hematol. 1996;33:127-138.
14. Foucar K. Chronic lymphoid leukemias and lymphoproliferative disorders. Mod Pathol. 1999;12:141-150.
15. Frizzera G, Wu CD, Inghirami G. The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. Am J Clin Pathol. 1999;111(suppl 1):S13-S39.
16. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML10 trial. Blood. 1998;92:2322-2333.
17. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
18. Horny HP, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Hum Pathol. 1985;16:808-814.
19. Kroft SH, McKenna RW. The bone marrow manifestations of Hodgkin's disease and non-Hodgkin's lymphomas and lymphoma-like disorders. In: Knowles DB, ed. Neoplastic Hematopathology. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:1447-1529.
20. Kyle RA, Greipp PR. Plasma cell dyscrasias: current status. Crit Rev Oncol Hematol. 1998;8:93-152.
21. Peterson L, Brunning RB. Bone specimen processing. In: Knowles DB, ed. Neoplastic Hematopathology, Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:1391-1405.
22. Pui CH, Campana D, Crist WM. Toward a clinically useful classification of the acute leukemias. Leukemia. 1995;9:2154-2157.
23. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood. 1993;81:2237-2251.
24. Valent P, Horny H-P, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603-625.
25. Zeleznik-Le NJ, Guiseppina N, Rowley JD. The molecular biology of myeloproliferative disorders as revealed by chromosomal abnormalities. Semin Hematol. 1995;32:201-219.